aid,target,target_type,active_count,inactive_count,total,name,function
1,NCI-H23,Cell Line,66,514,580,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Non-Small Cell Lung
3,NCI-H226,Cell Line,57,483,540,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Non-Small Cell Lung
5,NCI-H322M,Cell Line,57,516,573,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Non-Small Cell Lung
7,NCI-H460,Cell Line,74,481,555,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Non-Small Cell Lung
9,HOP-62,Cell Line,66,472,538,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Non-Small Cell Lung
11,HOP-18,Cell Line,28,87,115,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Non-Small Cell Lung
13,HOP-92,Cell Line,78,472,550,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Non-Small Cell Lung
15,NCI-H522,Cell Line,91,465,556,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Non-Small Cell Lung
17,LXFL 529,Cell Line,19,83,102,NCI human tumor cell line growth inhibition assay. Data for the LXFL 529 Non-Small Cell Lung cell line,Non-Small Cell Lung
19,A549,Cell Line,65,506,571,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Non-Small Cell Lung
21,EKVX,Cell Line,61,499,560,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Non-Small Cell Lung
23,LOX IMVI,Cell Line,81,474,555,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Melanoma
25,M14,Cell Line,57,488,545,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Melanoma
27,M19-MEL,Cell Line,26,108,134,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Melanoma
29,Malme-3M,Cell Line,69,452,521,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Melanoma
31,UACC-62,Cell Line,63,510,573,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Melanoma
33,UACC-257,Cell Line,59,514,573,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Melanoma
35,SK-MEL-2,Cell Line,67,494,561,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Melanoma
37,SK-MEL-5,Cell Line,76,496,572,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Melanoma
39,SK-MEL-28,Cell Line,63,503,566,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Melanoma
41,PC-3,Cell Line,61,421,482,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,prostate cancer
43,DU-145,Cell Line,51,428,479,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,prostate cancer
45,SF-268,Cell Line,70,501,571,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Central Nervous System
47,SF-295,Cell Line,64,518,582,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Central Nervous System
49,SF-539,Cell Line,71,477,548,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Central Nervous System
51,XF498,Cell Line,30,94,124,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Central Nervous System
53,SNB-19,Cell Line,59,525,584,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Central Nervous System
55,SNB-75,Cell Line,69,464,533,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Central Nervous System
57,SNB-78,Cell Line,25,95,120,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Central Nervous System
59,U-251,Cell Line,74,507,581,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Central Nervous System
61,DMS-273,Cell Line,29,98,127,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Small Cell Lung
63,DMS-114,Cell Line,27,105,132,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Small Cell Lung
65,HT-29,Cell Line,76,492,568,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Colon
67,COLO 205,Cell Line,69,508,577,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Colon
69,DLD-1,Cell Line,30,100,130,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Colon
71,HCT-15,Cell Line,78,505,583,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Colon
73,KM12,Cell Line,62,519,581,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Colon
75,KM-20L2,Cell Line,28,100,128,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Colon
77,HCC 2998,Cell Line,65,475,540,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Colon
79,HCT-116,Cell Line,82,501,583,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Colon
83,MCF7,Cell Line,73,426,499,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Breast
85,MDA-MB-435,Cell Line,56,426,482,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Breast
87,MDA-N,Cell Line,43,371,414,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Breast
89,BT-549,Cell Line,61,384,445,NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line,Breast
91,T47D,Cell Line,53,396,449,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Breast
93,ADR-RES,Cell Line,48,451,499,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Breast
95,MDA-MB-231,Cell Line,54,427,481,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Breast
97,Hs-578T,Cell Line,59,380,439,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Breast
99,OVCAR-3,Cell Line,73,490,563,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Ovarian
101,IGROV-1,Cell Line,65,509,574,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Ovarian
103,SK-OV-3,Cell Line,58,498,556,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Ovarian
105,OVCAR-4,Cell Line,60,504,564,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Ovarian
107,OVCAR-5,Cell Line,55,521,576,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Ovarian
109,OVCAR-8,Cell Line,70,509,579,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Ovarian
111,P388,Cell Line,21,21,42,NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line,Leukemia
113,RPMI-8226,Cell Line,88,436,524,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Leukemia
115,SR,Cell Line,72,413,485,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Leukemia
119,CCRF-CEM,Cell Line,103,450,553,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Leukemia
121,K562,Cell Line,84,469,553,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Leukemia
123,MOLT-4,Cell Line,81,488,569,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Leukemia
125,HL-60,Cell Line,103,399,502,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Leukemia
127,SN12K1,Cell Line,19,23,42,NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line,Renal
129,A498,Cell Line,67,457,524,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Renal
131,CAKI-1,Cell Line,70,497,567,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Renal
133,RXF 393,Cell Line,86,431,517,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Renal
137,786-0,Cell Line,67,484,551,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Renal
139,ACHN,Cell Line,57,498,555,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Renal
141,TK-10,Cell Line,61,474,535,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Renal
143,UO-31,Cell Line,63,507,570,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Renal
145,SN12C,Cell Line,67,511,578,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Renal
155,rad50,cancer,104,409,513,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,cancer
157,mec2-1,cancer,105,408,513,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,cancer
161,sgs1 mgt1,cancer,107,406,513,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,cancer
165,cln2 rad14,cancer,100,413,513,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,cancer
167,bub3,cancer,106,407,513,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,cancer
175,mlh1 rad18,cancer,109,402,511,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,cancer
328,BDF1,cancer,26,98,124,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,cancer
330,CDF1,cancer,39,330,369,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,cancer
410,cytochrome P450 1A2,Protein,30,83,113,p450-cyp1a2,Inhibitors
450,glucocorticoid receptor isoform gamma,Protein,18,117,135,GR-GFP Redistribution,Central Nervous System
884,cytochrome P450 3A4 isoform 1,Protein,55,146,201,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Inhibitors
899,cytochrome P450 2C19 precursor,Protein,21,92,113,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Inhibitors
1030,"aldehyde dehydrogenase 1 family, member A1",Protein,27,305,332,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Inhibitors
1460,Microtubule-associated protein tau,Protein,23,249,272,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Inhibitors
1578,NOD1,Protein,24,164,188,uHTS luminescence assay for the identification of compounds that inhibit NOD1,inflammatory disorders
1813,SNCA,Protein,23,200,223,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Parkinson
1851,CYP450,Protein,29,56,85,Cytochrome panel assay with activity outcomes,Inhibitors
2275,BJeLR,Cell Line,27,233,260,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,cancer
2313,shh,Pathway,27,263,290,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Inhibitors
2314,shiga toxin 1 A/B,Protein,21,223,244,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Inhibitors
2330,serine/threonine kinase 33,Protein,77,179,256,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Inhibitors
2551,nuclear receptor ROR-gamma isoform 2,Protein,40,386,426,qHTS for inhibitors of ROR gamma transcriptional activity,Inhibitors
2732,DNA damage-inducible transcript 3 protein,Protein,26,123,149,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Inhibitors
463190,TPA: protein transporter TIM10,Protein,30,297,327,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Inhibitors
485346,Mdm2/Mdm4,Protein,60,267,327,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Inhibitors
488899,Microphthalmia-associated transcription factor,Gene,26,277,303,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Inhibitors
504332,euchromatic histone-lysine N-methyltransferase 2,Protein,28,376,404,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Inhibitors
504444,nuclear factor erythroid 2-related factor 2 isoform 2,Protein,32,258,290,Nrf2 qHTS screen for inhibitors,Inhibitors
504558,LMP1 [Human herpesvirus 4],Protein,22,309,331,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Virus Antivirals
504749,Plasmodium falciparum,parasite,27,52,79,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Inhibitors
504834,malarial parasite,parasite,52,173,225,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Inhibitors
504847,vitamin D3 receptor isoform VDRA,Protein,34,536,570,Inhibitors of the vitamin D receptor (VDR): qHTS,Inhibitors
540276,gene 4 small orf - Marburg virus,Protein,21,84,105,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Virus Antivirals
588405,protein phosphatase 1 regulatory subunit 15A,Protein,37,318,355,HTS Assay for Peg3 Promoter Inhibitors,Inhibitors
588850,cystic fibrosis transmembrane conductance regulator,Protein,49,306,355,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Inhibitors
588855,Smad3,Protein,37,255,292,qHTS for Inhibitors of TGF-b,Inhibitors
602281,ABHD5/perilipin-5,Protein,22,335,357,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Inhibitors
624296,geminin,Protein,35,270,305,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,breast 
624297,geminin,Protein,26,304,330,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Colon
624352,endothelial PAS domain-containing protein 1,Protein,30,327,357,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Inhibitors
651633,p53,Pathway,32,213,245,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,small molecule agonists
651634,ATAD5,Cell Line,23,219,242,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,kidney
651635,Ataxin-2,Protein,23,316,339,Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression,Inhibitors
651661,EWS/Fli,Protein,26,297,323,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Inhibitors
651741,nuclear factor erythroid 2-related factor 2 isoform 1,Pathway,17,24,41,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,small molecule agonists
651820,HCV,Virus,26,257,283,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Virus Antivirals
652054,D(3) dopamine receptor isoform e,Protein,20,325,345,qHTS of D3 Dopamine Receptor Antagonist: qHTS,small molecule antagonists
652154,PAX8,Protein,34,203,237,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Inhibitors
686971,IDH1,Protein,46,264,310,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,cancer
686979,TDP1 protein,Protein,152,328,480,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Inhibitors
720532,Marburg Virus,Virus,33,269,302,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Virus Antivirals
720533,Lassa Virus,Virus,39,266,305,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Virus Antivirals
720552,Cellular tumor antigen p53,Pathway,17,218,235,qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,small molecule agonists
720579,Vaccinia Orthopoxvirus,Virus,30,376,406,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Virus Antivirals
720596,PRPC,Protein,23,315,338,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Inhibitors
720637,Mitochondrion membrane,Protein,34,181,215,qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,CellTox 
720692,glucocorticoid receptor [Homo sapiens],Pathway,39,143,182,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,small molecule antagonists
743012,DT40,Cell Line,69,154,223,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,CellTox 
743014,DT40,Cell Line,79,143,222,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,CellTox 
743015,DT40,Cell Line,77,147,224,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,CellTox 
743035,AR protein,Pathway,25,167,192,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,small molecule antagonists
743036,AR protein,Pathway,15,200,215,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,small molecule agonists
743040,AR protein,Pathway,23,224,247,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,small molecule agonists
743042,AR protein,Pathway,23,221,244,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,small molecule antagonists
743063,AR protein,Pathway,22,190,212,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,small molecule antagonists
743064,TR,Pathway,39,185,224,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,small molecule antagonists
743065,TR,Pathway,53,182,235,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,small molecule antagonists
743075,estrogen nuclear receptor alpha,Pathway,27,217,244,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,small molecule agonists
743079,estrogen nuclear receptor alpha,Pathway,32,175,207,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,small molecule agonists
743080,estrogen nuclear receptor alpha,Pathway,17,205,222,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,small molecule antagonists
743194,PPARg,Pathway,15,176,191,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,small molecule antagonists
743219,nuclear factor erythroid 2-related factor 2 isoform 1,Pathway,24,151,175,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,small molecule agonists
743224,VDR,Pathway,21,174,195,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,small molecule agonists
743279,interleukin-1 beta proprotein,Protein,61,282,343,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Inhibitors
1159521,RAR-related orphan receptor gamma,Pathway,30,176,206,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway ,small molecule antagonists
1159524,FMDV,Virus,29,409,438,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Virus Antivirals
1159529,RXR,Pathway,18,183,201,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,small molecule agonists
1159555,retinoic acid nuclear receptor alpha variant 1,Pathway,18,163,181,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,small molecule antagonists
1159606,TWEAK-Fn14,Protein,31,326,357,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Inhibitors
1224839,"nuclear receptor subfamily 1, group I, member 3",Pathway,13,200,213,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,small molecule agonists
1224841,estrogen-related nuclear receptor alpha,Pathway,24,191,215,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,small molecule antagonists
1224844,HIF-1,Pathway,24,187,211,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,small molecule agonists
1224847,H2AX,Protein,18,193,211,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,small molecule agonists
1224848,estrogen-related nuclear receptor alpha,Pathway,34,182,216,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,small molecule antagonists
1224871,HEK293,Cell Line,24,181,205,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,CellTox 
1224874,HEK293,Cell Line,27,185,212,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,CellTox 
1224879,HepG2,Cell Line,24,178,202,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,CellTox 
1224881,HEK293,Cell Line,20,189,209,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,CellTox 
1224883,HepG2,Cell Line,20,186,206,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,CellTox 
1224886,HEK293,Cell Line,26,186,212,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,CellTox 
1224889,HepG2,Cell Line,15,202,217,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,CellTox 
1259243,AR protein,Pathway,26,188,214,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,small molecule antagonists
1259248,estrogen nuclear receptor alpha,Pathway,16,190,206,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,small molecule antagonists
1259369,GLI family zinc finger 3,Pathway,39,153,192,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,small molecule antagonists
1259380,ER-beta,Pathway,30,172,202,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,small molecule agonists
1259381,AR protein,Pathway,25,201,226,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,small molecule agonists
1259382,ER-beta,Pathway,22,197,219,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,small molecule antagonists
1259415,HCMV,Virus,50,245,295,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Virus Antivirals
1259416,interferon gamma precursor,Protein,40,121,161,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Inhibitors
1259421,interferon gamma precursor,parasite,33,109,142,Toxoplasma gondii HTS in the absence of IFN-y,Inhibitors
1259422,transcriptional coactivator YAP1 isoform 1,parasite,19,173,192,Luminescence cell-based high throughput primary assay to identify inhibitors of TEAD-YAP interaction.,Inhibitors
1296008,,,100,614,714,Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening,CellTox 
1296009,MCC,,99,561,660,qHTS assay to identify novel small-molecules to repurpose for Merkel cell carcinoma treatment,cancer
1345082,NIH3T3,,123,196,319,Cytotoxic Profiling in NIH 3T3 Cell Line of Diverse Libraries Using Quantitative High-Throughput Screening,CellTox 
1345083,HEK293,,151,181,332,Cytotoxic Profiling in HEK 293 Cell Line of Diverse Libraries Using Quantitative High-Throughput Screening,CellTox 
1345084,,,72,567,639,Primary qHTS to identify gynecologic anti-cancer compounds using libraries of approved drugs and bioactive compounds,cancer
1345199,glioblastoma,Cell Line,51,65,116,Drug repurposing screens with cells derived from glioblastoma tumor samples,cancer
1346798,PR,Pathway,18,178,196,qHTS assay to identify small molecule antagonists of the progesterone receptor (PR) signaling pathway - cell viability counter screen,small molecule antagonists
1346799,PR,Pathway,15,163,178,qHTS assay to identify small molecule agonists of the progesterone receptor (PR) signaling pathway - cell viability counter screen,small molecule agonists
1346979,CHO-K1,Cell Line,25,178,203,"Caspase-3/7 induction in CHO-K1 cells by small molecules, qHTS cell viability counter screen",CellTox 
1346982,pregnane X nuclear receptor,Protein,74,141,215,"Human pregnane X receptor (PXR) small molecule agonists, qHTS assay",small molecule agonists
1346986,KB-3-1,Cell Line,54,610,664,"P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen",cancer
1346987,KB-8-5-11 ,Cell Line,73,577,650,"P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen",cancer
1347032,SMAD family member 2/3,Protein,11,196,207,"TGF-beta/Smad small molecule antagonists, qHTS assay: Summary",small molecule antagonists
1347060,SU-DIPG-XVII,,37,25,62,Diffuse intrinsic pontine glioma (SU-DIPG-XVII) cell line screen of MIPE5.0 library: viability qHTS assay using CellTiter-Glo,cancer
1347064,SU-DIPG-XIII,,27,28,55,Diffuse intrinsic pontine glioma (SU-DIPG-XIII) cell line screen of MIPE5.0 library: viability qHTS assay using CellTiter-Glo,cancer
1347065,SU-DIPG-XXV,,39,24,63,Diffuse intrinsic pontine glioma (SU-DIPG-XXV) cell line screen of MIPE5.0 library: viability qHTS assay using CellTiter-Glo,cancer
1347067,JHH-DIPG-1,,30,32,62,Diffuse intrinsic pontine glioma (JHH-DIPG-1) cell line screen of MIPE5.0 library: viability qHTS assay using CellTiter-Glo,cancer
1347075,MDR1,Gene,35,278,313,qHTS assay for MDR1-selective chemotherapeutics: Primary screen using the parental adenocarcinoma cell KB-3-1,cancer
1347076,ABCB1,Gene,29,264,293,qHTS assay for MDR1-selective chemotherapeutics: Primary screen using the drug-selected MDR subline cells KB-V1,cancer
1347083,Nucleoprotein,Protein,15,237,252,qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen,Virus Antivirals
1347085,Nucleoprotein,Protein,11,243,254,qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): Viability assay - alamar blue signal for LCMV Primary Screen,Virus Antivirals
1347092,A673,Cell Line,21,60,81,qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells,cancer
1347093,SK-N-MC,Cell Line,30,50,80,qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells,cancer
1347097,Saos-2,Cell Line,18,51,69,qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells,cancer
1347100,LAN-5,Cell Line,19,66,85,qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells,cancer
1347101,BT-12,Cell Line,18,58,76,qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells,cancer
1347103,OHS-50,Cell Line,23,43,66,qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells,cancer
1347131,"FMDV polyprotein, partial",Protein,11,436,447,qHTS Assay for Foot and Mouth Disease Virus Antivirals: Primary Screen against the MLPCN compound library,Virus Antivirals
1347159,NS2B-NS3 ,Protein,37,402,439,Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay,Virus Antivirals
1347160,NINDS,Virus,31,502,533,Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors,Virus Antivirals
1347417,Dd2,parasite,89,251,340,qHTS Primary assay for Inhibitors of Plasmodium falciparum Dd2 growth in vitro,Inhibitors
1645841,cytochrome P450 family 3 subfamily A polypeptide 4,Protein,20,46,66,Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) small molecule antagonists: luciferase cell-based qHTS assay,small molecule antagonists
1645855,Ubiquitin carboxyl-terminal hydrolase 17-like protein 5,Protein,21,136,157,USP17 deubiquitinase inhibition: Primary qHTS,Inhibitors
1645860,Ubiquitin carboxyl-terminal hydrolase 30,Protein,19,133,152,USP30 deubiquitinase inhibition: Primary qHTS,Inhibitors
1645876,Histone-lysine N-methyltransferase NSD2,Protein,132,458,590,Primary qHTS for inhibitors of nuclear receptor binding SET domain protein 2 (NSD2) in an isogenic RCH-ACV NSD2 p.E1099K mutant (9B),Inhibitors
1671190,Polyunsaturated fatty acid lipoxygenase ALOX12,Protein,16,900,916,Primary qHTS assay for inhibitors of human arachidonate 12S-lipoxygenase (ALOX12): Round 2,Inhibitors
1671193,SNCA,Protein,19,971,990,GF-AFC viability counterscreen for inhibitors of alpha-synuclein gene (SNCA) expression,Inhibitors
1671196,cytochrome P450 2D6,Protein,31,167,198,Cytochrome P450 Family 2 Subfamily D Member 6 (CYP2D6) small molecule antagonists: luciferase reporter qHTS assay,small molecule antagonists
1671197,"cytochrome P450, family 2, subfamily C, polypeptide 19",Protein,81,122,203,Cytochrome P450 Family 2 Subfamily C Member 19 (CYP2C19) small molecule antagonists: luciferase reporter qHTS assay,small molecule antagonists
1671198,cytochrome P450 family 2 subfamily C polypeptide 9,Protein,61,112,173,Cytochrome P450 Family 2 Subfamily C Member 9 (CYP2C9) small molecule antagonists: luciferase reporter qHTS assay,small molecule antagonists
1671199,"cytochrome P450, family 1, subfamily A, polypeptide 2",Protein,50,123,173,Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: luciferase reporter qHTS assay,small molecule antagonists
1671201,cytochrome P450 family 3 subfamily A polypeptide 4,Protein,64,147,211,Cytochrome P450 Family 3 Subfamily A Member 4 (CYP3A4) small molecule antagonists: luciferase reporter qHTS assay,small molecule antagonists
1745845,Ataxin-2,Protein,35,328,363,Primary qHTS for Inhibitors of ATXN expression,Inhibitors
1745853,Methyltransferases,Protein,25,619,644,Primary Screen for Target Class Profiling of Small Molecule Inhibitors of Methyltransferases,Inhibitors
1794795,SW-620,Cell Line,21,233,254,"NCI human tumor cell line growth inhibition assay. Data for the SW-620 Non-Small Cell Lung cell line, single concentration",Non-Small Cell Lung
